The deletion polymorphisms or low levels of messenger RNA (mRNA) of the proapoptotic Bcl-2 family member, BIM, enabled the tumor to resist the apoptosis effects of EGFR-TKI [12]. This evidence concerns the gene EGFR and neoplasm.